AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$567M |
| 2 |
Visa
V
|
+$283M |
| 3 |
CVS Health
CVS
|
+$195M |
| 4 |
Texas Instruments
TXN
|
+$188M |
| 5 |
Progressive
PGR
|
+$187M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$274M |
| 2 |
Microsoft
MSFT
|
+$263M |
| 3 |
Comcast
CMCSA
|
+$248M |
| 4 |
Amphenol
APH
|
+$238M |
| 5 |
Elevance Health
ELV
|
+$238M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.59% |
| 2 | Financials | 14.66% |
| 3 | Healthcare | 14.25% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Williams-Sonoma
WSM
$26.7B
| $3.46M | ﹤0.01% |
135,284
-740
| -0.5% | -$19.4K |
|
|
CEB
1352
DELISTED
CEB Inc.
CEB
| $3.45M | ﹤0.01% |
63,413
-1,200
| -2% | -$71.8K |
|
1353
Pinnacle Financial Partners Inc
PNFP
$15.5B
| $3.45M | ﹤0.01% |
63,730
-1,261
| -2% | -$68K |
|
1354
SS&C Technologies
SSNC
$17.8B
| $3.44M | ﹤0.01% |
106,918
-50
| -0% | -$1.58K |
|
|
ARRS
1355
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $3.44M | ﹤0.01% |
121,243
-574
| -0.5% | -$15.3K |
|
|
SPR
1356
DELISTED
Spirit AeroSystems
SPR
| $3.43M | ﹤0.01% |
77,040
-14,300
| -16% | -$632K |
|
|
KITE
1357
DELISTED
Kite Pharma, Inc.
KITE
| $3.43M | ﹤0.01% |
61,400
| – | – |
|
|
BGG
1358
DELISTED
Briggs & Stratton Corp.
BGG
| $3.42M | ﹤0.01% |
183,475
+83,050
| +83% | +$1.71M |
|
1359
Babcock & Wilcox
BW
$1.43B
| $3.42M | ﹤0.01% |
20,725
+14,565
| +236% | +$2.33M |
|
1360
Copart
CPRT
$25.9B
| $3.42M | ﹤0.01% |
510,656
-3,360
| -0.7% | -$21.4K |
|
1361
ANI Pharmaceuticals
ANIP
$1.77B
| $3.41M | ﹤0.01% |
51,450
+23,770
| +86% | +$1.49M |
|
|
PEI
1362
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $3.41M | ﹤0.01% |
9,884
-3,820
| -28% | -$1.37M |
|
|
NYRT
1363
DELISTED
New York REIT, Inc.
NYRT
| $3.41M | ﹤0.01% |
37,224
+1,574
| +4% | +$150K |
|
1364
Dick's Sporting Goods
DKS
$18.4B
| $3.4M | ﹤0.01% |
60,018
-46
| -0.1% | -$2.53K |
|
1365
Gibraltar Industries
ROCK
$1.34B
| $3.4M | ﹤0.01% |
91,520
+30,070
| +49% | +$1.1M |
|
|
TPH
1366
DELISTED
Tri Pointe Homes
TPH
| $3.39M | ﹤0.01% |
257,521
+1,871
| +0.7% | +$24.7K |
|
1367
Alnylam Pharmaceuticals
ALNY
$36.3B
| $3.39M | ﹤0.01% |
50,064
-150
| -0.3% | -$10.6K |
|
1368
Archrock
AROC
$6.33B
| $3.39M | ﹤0.01% |
259,360
+158,360
| +157% | +$1.7M |
|
1369
Carter's
CRI
$1.43B
| $3.39M | ﹤0.01% |
39,064
-255
| -0.6% | -$25.6K |
|
1370
Brookfield
BN
$102B
| $3.38M | ﹤0.01% |
269,183
-632,759
| -70% | -$7.75M |
|
1371
Meritage Homes
MTH
$4.87B
| $3.38M | ﹤0.01% |
194,636
-3,678,226
| -95% | -$66.8M |
|
1372
Commerce Bancshares
CBSH
$8.5B
| $3.37M | ﹤0.01% |
111,477
-1,140
| -1% | -$34K |
|
1373
Novartis
NVS
$295B
| $3.37M | ﹤0.01% |
47,601
+9,358
| +24% | +$682K |
|
|
HMSY
1374
DELISTED
HMS Holdings Corp.
HMSY
| $3.36M | ﹤0.01% |
151,717
-5,200
| -3% | -$109K |
|
1375
Bio-Rad Laboratories Class A
BIO
$8.42B
| $3.35M | ﹤0.01% |
20,465
+6,125
| +43% | +$930K |
|
Similar funds
AllianceBernstein's Q3 2016 Portfolio in Review
As of Q3 2016, AllianceBernstein held 3,058 positions worth $118B, up 2% from $116B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AllianceBernstein's Q3 2016 filing shows 95 new, 1,049 increased, 1,331 reduced and 82 closed positions. Its largest new stake was Teva Pharmaceuticals: 2,294,681 shares worth $106M. The largest sale was Pfizer, an estimated $274M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- AllianceBernstein's largest Q3 2016 buy was Teva Pharmaceuticals: 2,294,681 shares worth $106M.
- AllianceBernstein added most to State Street SPDR S&P 500 ETF Trust in Q3 2016, an estimated $567M increase.
- AllianceBernstein's biggest Q3 2016 reduction was Pfizer, cutting an estimated $274M.
- AllianceBernstein fully exited EMC CORPORATION in Q3 2016, selling an estimated $99.6M.
- AllianceBernstein's ten largest holdings make up 14% of its $118B portfolio in Q3 2016.
- AllianceBernstein opened 95 new positions and closed 82 in Q3 2016.
- AllianceBernstein's portfolio value rose 2% quarter-over-quarter to $118B.
Based on AllianceBernstein's 13F filing for Q3 2016, filed 10 Nov 2016.